about
Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.Targeting IRAK1 in T-cell acute lymphoblastic leukemiaTargeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma.Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
IRAK1: oncotarget in MDS and AML.
@en
IRAK1: oncotarget in MDS and AML.
@nl
type
label
IRAK1: oncotarget in MDS and AML.
@en
IRAK1: oncotarget in MDS and AML.
@nl
prefLabel
IRAK1: oncotarget in MDS and AML.
@en
IRAK1: oncotarget in MDS and AML.
@nl
P2860
P356
P1433
P1476
IRAK1: oncotarget in MDS and AML.
@en
P2093
Daniel T Starczynowski
Levil J Beverly
P2860
P304
P356
10.18632/ONCOTARGET.1880
P407
P577
2014-04-01T00:00:00Z